Analytical Quality by Design (AQbD) Approach to the Development of In Vitro Release Test for Topical Hydrogel
Open Access
- 26 March 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (4) , 707
Abstract
The aim of our study was to adapt the analytical quality by design (AQbD) approach to design an effective in vitro release test method using USP apparatus IV with a semi-solid adapter (SSA) for diclofenac sodium hydrogel. The analytical target profile (ATP) of the in vitro release test and ultra-high-performance liquid chromatography were defined; the critical method attributes (CMAs) (min. 70% of the drug should be released during the test, six time points should be obtained in the linear portion of the drug release profile, and the relative standard deviation of the released drug should not be over 10%) were selected. An initial risk assessment was carried out, in which the CMAs (ionic strength, the pH of the media, membrane type, the rate of flow, the volume of the SSA (sample amount), the individual flow rate of cells, drug concentration %, and the composition of the product) were identified. With the results, it was possible to determine the high-risk parameters of the in vitro drug release studies performed with the USP apparatus IV with SSA, which were the pH of the medium and the sample weight of the product. Focusing on these parameters, we developed a test protocol for our hydrogel system.Keywords
Funding Information
- Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund (TKP2021-EGA-32)
This publication has 17 references indexed in Scilit:
- Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design methodEuropean Journal of Pharmaceutical Sciences, 2017
- A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC–MS methods development for protein analysisJournal of Pharmaceutical and Biomedical Analysis, 2016
- Analytical Quality by Design Approach to Test Method Development and Validation in Drug Substance ManufacturingJournal of Chemistry, 2015
- A quality by design (QbD) case study on enteric-coated pellets: Screening of critical variables and establishment of design space at laboratory scaleAsian Journal of Pharmaceutical Sciences, 2014
- Generic Development of Topical Dermatologic Products, Part II: Quality by Design for Topical Semisolid ProductsThe AAPS Journal, 2013
- Quality by Design I: Application of Failure Mode Effect Analysis (FMEA) and Plackett–Burman Design of Experiments in the Identification of “Main Factors” in the Formulation and Process Design Space for Roller-Compacted Ciprofloxacin Hydrochloride Immediate-Release TabletsAAPS PharmSciTech, 2012
- The New European Medicines Agency Guideline on the Investigation of BioequivalenceBasic & Clinical Pharmacology & Toxicology, 2010
- Topical and Transdermal Drug ProductsDissolution Technologies, 2010
- Investigation of dissolution behavior of diclofenac sodium extended release formulations under standard and biorelevant test conditionsDrug Development and Industrial Pharmacy, 2009
- Some Factors Affecting the Release of a Water-Soluble Drug from a Compressed Hydrophilic MatrixJournal of Pharmaceutical Sciences, 1966